Gene Review:
Bche - butyrylcholinesterase
Mus musculus
Synonyms:
Acylcholine acylhydrolase, Butyrylcholine esterase, C730038G20Rik, Choline esterase II, Cholinesterase, ...
- Muscular dystrophy alters the processing of light acetylcholinesterase but not butyrylcholinesterase forms in liver of Lama2(dy) mice. Gómez, J.L., García-Ayllón, M.S., Campoy, F.J., Vidal, C.J. J. Neurosci. Res. (2000)
- Respiratory survival mechanisms in acetylcholinesterase knockout mouse. Chatonnet, F., Boudinot, E., Chatonnet, A., Taysse, L., Daulon, S., Champagnat, J., Foutz, A.S. Eur. J. Neurosci. (2003)
- Muscular dystrophy with laminin deficiency decreases the content of butyrylcholinesterase tetramers in sciatic nerves of Lama2dy mice. Moral-Naranjo, M.T., Cabezas-Herrera, J., Vidal, C.J., Campoy, F.J. Neurosci. Lett. (2002)
- Activation of acetyl- and butyrylcholinesterase by enzymatic removal of sialic acid from intact neuroblastoma and astroblastoma cells in culture. Stefanovic, V., Mandel, P., Rosenberg, A. Biochemistry (1975)
- Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice. Clement, J.G. Biochem. Pharmacol. (1984)
- Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent. Greig, N.H., Utsuki, T., Ingram, D.K., Wang, Y., Pepeu, G., Scali, C., Yu, Q.S., Mamczarz, J., Holloway, H.W., Giordano, T., Chen, D., Furukawa, K., Sambamurti, K., Brossi, A., Lahiri, D.K. Proc. Natl. Acad. Sci. U.S.A. (2005)
- Effects of inescapable stress and treatment with pyridostigmine bromide on plasma butyrylcholinesterase and the acoustic startle response in rats. Servatius, R.J., Ottenweller, J.E., Guo, W., Beldowicz, D., Zhu, G., Natelson, B.H. Physiol. Behav. (2000)
- Characterization of equine butyrylcholinesterase disposition in the mouse. Koetzner, L., Woods, J.H. Drug Metab. Dispos. (2002)
- Molecular cloning of mouse acetylcholinesterase: tissue distribution of alternatively spliced mRNA species. Rachinsky, T.L., Camp, S., Li, Y., Ekström, T.J., Newton, M., Taylor, P. Neuron (1990)
- Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. Feng, G., Krejci, E., Molgo, J., Cunningham, J.M., Massoulié, J., Sanes, J.R. J. Cell Biol. (1999)
- Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease. Liston, D.R., Nielsen, J.A., Villalobos, A., Chapin, D., Jones, S.B., Hubbard, S.T., Shalaby, I.A., Ramirez, A., Nason, D., White, W.F. Eur. J. Pharmacol. (2004)
- Organophosphorus pesticide-induced butyrylcholinesterase inhibition and potentiation of succinylcholine toxicity in mice. Sparks, S.E., Quistad, G.B., Casida, J.E. J. Biochem. Mol. Toxicol. (1999)
- Perchloroethylene: effects on body and organ weights and plasma butyrylcholinesterase activity in mice. Kjellstrand, P., Holmquist, B., Kanje, M., Alm, P., Romare, S., Jonsson, I., Månsson, L., Bjerkemo, M. Acta pharmacologica et toxicologica. (1984)
- Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice. Adler, M., Manley, H.A., Purcell, A.L., Deshpande, S.S., Hamilton, T.A., Kan, R.K., Oyler, G., Lockridge, O., Duysen, E.G., Sheridan, R.E. Muscle Nerve (2004)
- Thymus Acetylcholinesterase Activity is Reduced in Mice With Congenital Muscular Dystrophy. Nieto-Cer??n, S., Del Campo, L.F., Delgado, E.M., Vidal, C.J., Campoy, F.J. J. Mol. Neurosci. (2006)
- Remodeling of the neuromuscular junction in mice with deleted exons 5 and 6 of acetylcholinesterase. Girard, E., Bernard, V., Camp, S., Taylor, P., Krejci, E., Molg??, J. J. Mol. Neurosci. (2006)
- Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase. Boudinot, E., Taysse, L., Daulon, S., Chatonnet, A., Champagnat, J., Foutz, A.S. Pharmacol. Biochem. Behav. (2005)
- Inhibitory effects of huperzine B on cholinesterase activity in mice. Liu, J., Zhang, H.Y., Wang, L.M., Tang, X.C. Zhongguo yao li xue bao = Acta pharmacologica Sinica. (1999)
- Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions. Minic, J., Chatonnet, A., Krejci, E., Molgó, J. Br. J. Pharmacol. (2003)
- The effects of some porphyrinogenic drugs on the brain cholinergic system. Rodriguez, J.A., Buzaleh, A.M., Fossati, M., Azcurra, J., Batlle, A.M. Cell. Mol. Biol. (Noisy-le-grand) (2002)
- Time course of neocortical graft innervation by AChE-positive fibers. Clinton, R.J., Ebner, F.F. J. Comp. Neurol. (1988)
- Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. Xie, W., Stribley, J.A., Chatonnet, A., Wilder, P.J., Rizzino, A., McComb, R.D., Taylor, P., Hinrichs, S.H., Lockridge, O. J. Pharmacol. Exp. Ther. (2000)
- Molecular forms of acetyl- and butyrylcholinesterase in normal and dystrophic mouse brain. Moral-Naranjo, M.T., Cabezas-Herrera, J., Vidal, C.J. J. Neurosci. Res. (1996)
- The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase. Morton, C.L., Wadkins, R.M., Danks, M.K., Potter, P.M. Cancer Res. (1999)
- Trichloroethylene: further studies of the effects on body and organ weights and plasma butyrylcholinesterase activity in mice. Kjellstrand, P., Holmquist, B., Alm, P., Kanje, M., Romare, S., Jonsson, I., Månsson, L., Bjerkemo, M. Acta pharmacologica et toxicologica. (1983)
- Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality. Duysen, E.G., Li, B., Xie, W., Schopfer, L.M., Anderson, R.S., Broomfield, C.A., Lockridge, O. J. Pharmacol. Exp. Ther. (2001)
- Amyloid precursor protein fragment and acetylcholinesterase increase with cell confluence and differentiation in a neuronal cell line. Bronfman, F.C., Fernandez, H.L., Inestrosa, N.C. Exp. Cell Res. (1996)
- Synthesis and cholinergic properties of N-aryl-2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethylamino analogs of ranitidine. Valli, M.J., Tang, Y., Kosh, J.W., Chapman, J.M., Sowell, J.W. J. Med. Chem. (1992)
- Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity. Snyder, S.E., Gunupudi, N., Sherman, P.S., Butch, E.R., Skaddan, M.B., Kilbourn, M.R., Koeppe, R.A., Kuhl, D.E. J. Cereb. Blood Flow Metab. (2001)
- Characterization of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate. Lapadula, D.M., Patton, S.E., Campbell, G.A., Abou-Donia, M.B. Toxicol. Appl. Pharmacol. (1985)
- Tritium labeling of a powerful methylphosphonate inhibitor of cholinesterase: synthesis and biological applications. Balan, A., Barness, I., Simon, G., Levy, D., Ashani, Y. Anal. Biochem. (1988)
- Tissue distribution of human acetylcholinesterase and butyrylcholinesterase messenger RNA. Jbilo, O., Bartels, C.F., Chatonnet, A., Toutant, J.P., Lockridge, O. Toxicon (1994)
- Localization of mRNAs encoding acetylcholinesterase and butyrylcholinesterase in the rat spinal cord by nonradioactive in situ hybridization. Mis, K., Mars, T., Jevsek, M., Brank, M., Zajc-Kreft, K., Grubic, Z. J. Histochem. Cytochem. (2003)